Vaccination with long NY-ESO-1 79-108 peptide and CpG-B leads to robust activation of CD4 and CD8 T cell responses in stage III/IV melanoma patients, and a new HLA-DR7 epitope
===============================================================================================================================================================================

* Petra Baumgartner
* Carla Costa Nunes
* Amélie Cachot
* Hélène Maby-El Hajjami
* Laurène Cagnon
* Marion Braun
* Laurent Derré
* Jean-Paul Rivals
* Donata Rimoldi
* Emanuela Romano
* Olivier Michielin
* Pedro Romero
* Camilla Jandus
* Daniel E Speiser